Header Logo

Connection

MATTHEW TORRE to Male

Back to Details
This is a "connection" page, showing publications MATTHEW TORRE has written about Male.
MATTHEW TORRE
Connection Strength
0.291
Male
  1. Elevated Oxidative Stress and DNA Damage in Cortical Neurons of Chemotherapy Patients. J Neuropathol Exp Neurol. 2021 08 11; 80(7):705-712.
    View in: PubMed
    Score: 0.029
  2. Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathol Commun. 2020 07 14; 8(1):107.
    View in: PubMed
    Score: 0.027
  3. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis. J Am Soc Cytopathol. 2020 Jan - Feb; 9(1):45-54.
    View in: PubMed
    Score: 0.025
  4. Characterization of molecular signatures of supratentorial ependymomas. Mod Pathol. 2020 01; 33(1):47-56.
    View in: PubMed
    Score: 0.025
  5. Recurrent EP300-BCOR Fusions in Pediatric Gliomas With Distinct Clinicopathologic Features. J Neuropathol Exp Neurol. 2019 04 01; 78(4):305-314.
    View in: PubMed
    Score: 0.025
  6. Neuropathology of a Case With Fatal CAR T-Cell-Associated Cerebral Edema. J Neuropathol Exp Neurol. 2018 10 01; 77(10):877-882.
    View in: PubMed
    Score: 0.024
  7. Expanding the spectrum of pediatric NTRK-rearranged fibroblastic tumors to the central nervous system: A case report with RBPMS-NTRK3 fusion. Neuropathology. 2018 Dec; 38(6):624-630.
    View in: PubMed
    Score: 0.024
  8. Embolic Foreign Material in the Central Nervous System of Pediatric Autopsy Patients With Instrumented Heart Disease. J Neuropathol Exp Neurol. 2017 Jul 01; 76(7):571-577.
    View in: PubMed
    Score: 0.022
  9. Osseous and chondromatous metaplasia in calcific aortic valve stenosis. Cardiovasc Pathol. 2016 Jan-Feb; 25(1):18-24.
    View in: PubMed
    Score: 0.019
  10. Sensory-selective Peripheral and Neuraxial Nerve Blockade with 2',6'-Pipecoloxylidide. Anesthesiology. 2025 Nov 01; 143(5):1296-1312.
    View in: PubMed
    Score: 0.010
  11. Enhanced Control of Liposomal Drug Release by Drug-Aptamer Complexes. Adv Mater. 2025 Oct; 37(40):e2503872.
    View in: PubMed
    Score: 0.010
  12. The epidemiology of primary and metastatic brain tumors in infancy through childhood. J Neurooncol. 2022 Jan; 156(2):419-429.
    View in: PubMed
    Score: 0.007
  13. IDH-mutant gliomas with additional class-defining molecular events. Mod Pathol. 2021 07; 34(7):1236-1244.
    View in: PubMed
    Score: 0.007
  14. Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplastic Kelch-like Protein-11 Encephalitis. JAMA Neurol. 2020 11 01; 77(11):1420-1429.
    View in: PubMed
    Score: 0.007
  15. Molecular characterization of diffuse malignant peritoneal mesothelioma. Mod Pathol. 2020 11; 33(11):2269-2279.
    View in: PubMed
    Score: 0.007
  16. Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomas. Neuro Oncol. 2020 03 05; 22(3):369-380.
    View in: PubMed
    Score: 0.007
  17. Neurological toxicities associated with chimeric antigen receptor T-cell therapy. Brain. 2019 05 01; 142(5):1334-1348.
    View in: PubMed
    Score: 0.006
  18. The Misclassification of Diffuse Gliomas: Rates and Outcomes. Clin Cancer Res. 2019 04 15; 25(8):2656-2663.
    View in: PubMed
    Score: 0.006
  19. Immune-related fulminant myocarditis in a patient receiving ipilimumab therapy for relapsed chronic myelomonocytic leukaemia. Eur J Heart Fail. 2017 05; 19(5):682-685.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.